WallStSmart
ALDX

Aldeyra The

NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY

$1.71
-7.39% today

Updated 2026-06-05

Market cap
$98.93M
P/E ratio
P/S ratio
EPS (TTM)
$-0.45
Dividend yield
52W range
$1 – $6
Volume
1.4M

Aldeyra The (ALDX) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-22.20%
Debt/equity
0.37x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2011$-2.38M
2012$-23.07M
2013$13.06M
2014$0.00$-5.19M
2015$0.00$-12.09M
2016$0.00$-18.70M
2017$0.00$-22.34M
2018$0.00$-38.89M
2019$0.00$-60.83M
2020$0.00$-37.55M
2021$0.00$-57.78M
2022$0.00$-62.02M
2023$0.00$-37.54M
2024$0.00$-55.85M
2025$0.00$-33.85M

Frequently asked questions

How much free cash flow does ALDX generate?

ALDX produced $-33.35M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ALDX's balance sheet healthy?

ALDX holds $70.04M in cash and equivalents against — in long-term debt, on $44.25M of shareholder equity. That debt is best read against the cash flow the business throws off each year.